{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensified or comparative risk adjective.", "method": "llm_batch", "batch_id": "batch_1_3500", "batch_size": 260, "batch_pos": 235, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
